News and Comments

The FDA Approval Of Kynamro™ Promises ISIS A Bright Future Read Also about ALNY; Sarepta, SNY

  Thursday, January 31, 2013

 More...

REGENERON: A GREAT LESSON TO LEARN

  Thursday, May 05, 2011

First, we congratulate our subscribers who did not follow the skeptics and believed in the rationality of science and kept their Vertex’ (VRTX) and Regeneron’s (REGN) shares despite years of negative campaigns against the two firms. Following the rally in VRTX, another rally started in REGN for rational reasons. Both firms are among our TOP TEN selection. More...


Recent Postings


Archive


Tags

Alnylam (ALNY) Human Longevity (HLI) Sequenom (SQNM) OSI (OSIP) BIOMARIN (BMRN) RenenxBio (RGNX) Vertex (VRTX) Benlysta (belimumab) Anacor (ANAC) AERIE PHARMACEUTICALS Exelixis (EXEL) ABBVIE (ABBV) Dendreon (DNDN) Mirati Therapeutics (MRTX) Multiple Myeloma Sarepta (SRPT) ImmunoGen (IMGN) ARCA (ABIO) Idenix (IDIX) Sangamo (SGMO) Abbott Laboratories (ABT) IDERA (IDRA) Galena (GALE) Intercept (ICPT) Incyte (INCY) Theravance Bio Pharma (TBPH) Merck (MRK) Tysabri Biocryst (BCRX) Gilead (GILD) ZALTRAP™ SUNESIS PHARMACEUTICALS (SNSS) REGULUS (RGLS) Illumina (ILMN) Revlimid (lenolidamide) Anadys (ANDS) Jazz Pharmaceuticals (JAZZ) ADVENTRIX (ANX) Ariad (ARIA) Intermune (ITMN) Inovio (INO) Genentech Amgen (AMGN) NEKTAR (NKTR)) Intrexon (XON) CompuGen (CGEN) ACADIA (ACAD) Sanofi-Aventis (SAN) PTC Therapeutics (PTCT) ISIS (ISIS) Alder Biopharmaceuticals (ALDR) NANTKWEST (NK) Prolor Biotech (PBTH) Pluristem (PSTI) Editas (EDIT) galapagos (GLPG) Velcade (bortezomib) Roche (ROCHE) Agenus (AGEN) KITE (KITE) Micromet (MITI) Xoma (XOMA) Onyx (ONXX) Herceptin Roche (RHHBY) Seattle Genetics (SGEN) GUARDIAN HEALTH Cytokinetics (CYTK) GlaxoSmithKline (GSK) Theravance (THRX) Regeneron (REGN) Prosensa (RNA) HALOZYME (HALO) Biogen Idec (BIIB) Auspex (ASPX) Ionis (IONS) SYNTA (SNTA) Valeant Pharmaceuticals International (VRX) Ziofpharm (ZIOP) JUNO (JUNO) TOKAI (TKAOI) Array Pharmaceuticals (ARRY) Agenus (AGEN Aimmune Therapeutics (AIMT) Trastuzumab-DM1 Bristol-Myers Squibb (BMY) Telaprevir Rapamune Elan (ELN) Human Genome Sciences (HGSI) Sanofi (SNA) C4 Therapeutics KERYX (KERX) Endometrial Cancer Ridaforolimus SERES THERAPEUTICS (MCRB) Vitae Pharmaceuticals (VTAE) Zerenex Sanofi (SNY) Dynavax (DVAX) VANDA (VNDA)